Report for Tsolaki M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (14)

Title : Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - Dubois_2023_Alzheimers.Res.Ther_15_39
Author(s) : Dubois B , Lopez-Arrieta J , Lipschitz S , Triantafyllos D , Spiru L , Moroz S , Venger O , Vermersch P , Moussy A , Mansfield CD , Hermine O , Tsolaki M
Ref : Alzheimers Res Ther , 15 :39 , 2023
Abstract : Dubois_2023_Alzheimers.Res.Ther_15_39
ESTHER : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedSearch : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedID: 36849969

Title : Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life -
Author(s) : Nifli AP , Tsolaki M , Tournoy J , Ide K
Ref : Front Pharmacol , 11 :618344 , 2020
PubMedID: 33584301

Title : The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease - Kazmierski_2018_Am.J.Alzheimers.Dis.Other.Demen__1533317518775044
Author(s) : Kazmierski J , Messini-Zachou C , Gkioka M , Tsolaki M
Ref : Am J Alzheimers Dis Other Demen , :1533317518775044 , 2018
Abstract : Kazmierski_2018_Am.J.Alzheimers.Dis.Other.Demen__1533317518775044
ESTHER : Kazmierski_2018_Am.J.Alzheimers.Dis.Other.Demen__1533317518775044
PubMedSearch : Kazmierski_2018_Am.J.Alzheimers.Dis.Other.Demen__1533317518775044
PubMedID: 29742912

Title : No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease - Chiam_2015_J.Alzheimers.Dis_47_741
Author(s) : Chiam JT , Lunnon K , Voyle N , Proitsi P , Coppola G , Geschwind D , Nelson S , Johnston C , Soininen H , Kloszewska I , Mecocci P , Tsolaki M , Vellas B , Hodges A , Lovestone S , Newhouse S , Dobson RJ , Kiddle SJ , Sattlecker M
Ref : J Alzheimers Dis , 47 :741 , 2015
Abstract : Chiam_2015_J.Alzheimers.Dis_47_741
ESTHER : Chiam_2015_J.Alzheimers.Dis_47_741
PubMedSearch : Chiam_2015_J.Alzheimers.Dis_47_741
PubMedID: 26401708

Title : Clinical efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors, in patients with cognitive impairment: a comparative open study - Koliaki_2012_CNS.Neurosci.Ther_18_302
Author(s) : Koliaki CC , Messini C , Tsolaki M
Ref : CNS Neurosci Ther , 18 :302 , 2012
Abstract : Koliaki_2012_CNS.Neurosci.Ther_18_302
ESTHER : Koliaki_2012_CNS.Neurosci.Ther_18_302
PubMedSearch : Koliaki_2012_CNS.Neurosci.Ther_18_302
PubMedID: 22070796

Title : Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease - Emre_2010_CNS.Neurosci.Ther_16_246
Author(s) : Emre M , Bernabei R , Blesa R , Bullock R , Cunha L , Daniels H , Dziadulewicz E , Forstl H , Frolich L , Gabryelewicz T , Levin O , Lindesay J , Martinez-Lage P , Monsch A , Tsolaki M , van Laar T
Ref : CNS Neurosci Ther , 16 :246 , 2010
Abstract : Emre_2010_CNS.Neurosci.Ther_16_246
ESTHER : Emre_2010_CNS.Neurosci.Ther_16_246
PubMedSearch : Emre_2010_CNS.Neurosci.Ther_16_246
PubMedID: 20370805

Title : Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease - Kountouras_2009_J.Neurol_256_758
Author(s) : Kountouras J , Boziki M , Gavalas E , Zavos C , Grigoriadis N , Deretzi G , Tzilves D , Katsinelos P , Tsolaki M , Chatzopoulos D , Venizelos I
Ref : Journal of Neurology , 256 :758 , 2009
Abstract : Kountouras_2009_J.Neurol_256_758
ESTHER : Kountouras_2009_J.Neurol_256_758
PubMedSearch : Kountouras_2009_J.Neurol_256_758
PubMedID: 19240960

Title : Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey - Froelich_2009_Curr.Med.Res.Opin_25_3059
Author(s) : Froelich L , Andreasen N , Tsolaki M , Foucher A , Kavanagh S , Baelen BV , Schwalen S
Ref : Curr Med Res Opin , 25 :3059 , 2009
Abstract : Froelich_2009_Curr.Med.Res.Opin_25_3059
ESTHER : Froelich_2009_Curr.Med.Res.Opin_25_3059
PubMedSearch : Froelich_2009_Curr.Med.Res.Opin_25_3059
PubMedID: 19852697

Title : Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine* - Nieoullon_2008_Curr.Med.Res.Opin_24_3357
Author(s) : Nieoullon A , Bentue-Ferrer D , Bordet R , Tsolaki M , Forstl H
Ref : Curr Med Res Opin , 24 :3357 , 2008
Abstract : Nieoullon_2008_Curr.Med.Res.Opin_24_3357
ESTHER : Nieoullon_2008_Curr.Med.Res.Opin_24_3357
PubMedSearch : Nieoullon_2008_Curr.Med.Res.Opin_24_3357
PubMedID: 19032118

Title : Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II - Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
Author(s) : Aalten P , Verhey FR , Boziki M , Brugnolo A , Bullock R , Byrne EJ , Camus V , Caputo M , Collins D , De Deyn PP , Elina K , Frisoni G , Holmes C , Hurt C , Marriott A , Mecocci P , Nobili F , Ousset PJ , Reynish E , Salmon E , Tsolaki M , Vellas B , Robert PH
Ref : Dementia & Geriatric Cognitive Disorders , 25 :1 , 2008
Abstract : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
ESTHER : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
PubMedSearch : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
PubMedID: 18025783

Title : Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy - Sakka_2007_Curr.Med.Res.Opin_23_3153
Author(s) : Sakka P , Tsolaki M , Hort J , Hager K , Soininen H , Lopez Pousa S , Li C , Schwam E
Ref : Curr Med Res Opin , 23 :3153 , 2007
Abstract : Sakka_2007_Curr.Med.Res.Opin_23_3153
ESTHER : Sakka_2007_Curr.Med.Res.Opin_23_3153
PubMedSearch : Sakka_2007_Curr.Med.Res.Opin_23_3153
PubMedID: 17988434

Title : Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study - Tsolaki_2001_J.Int.Med.Res_29_28
Author(s) : Tsolaki M , Pantazi T , Kazis A
Ref : J Internal Medicine Res , 29 :28 , 2001
Abstract : Tsolaki_2001_J.Int.Med.Res_29_28
ESTHER : Tsolaki_2001_J.Int.Med.Res_29_28
PubMedSearch : Tsolaki_2001_J.Int.Med.Res_29_28
PubMedID: 11277345

Title : Rivastigmine for Alzheimer's disease - Birks_2000_Cochrane.Database.Syst.Rev__CD001191
Author(s) : Birks J , Iakovidou V , Tsolaki M
Ref : Cochrane Database Syst Rev , :CD001191 , 2000
Abstract : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
ESTHER : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
PubMedSearch : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
PubMedID: 10796621

Title : Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report - Fotiou_2000_Int.J.Psychophysiol_37_111
Author(s) : Fotiou F , Fountoulakis KN , Tsolaki M , Goulas A , Palikaras A
Ref : Int J Psychophysiol , 37 :111 , 2000
Abstract : Fotiou_2000_Int.J.Psychophysiol_37_111
ESTHER : Fotiou_2000_Int.J.Psychophysiol_37_111
PubMedSearch : Fotiou_2000_Int.J.Psychophysiol_37_111
PubMedID: 10828379